EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IMMUND: A Diagnostic and Therapeutic Pipeline to Uncover the Convergence in Functional Perturbation at Early Stages of Neurodegenerative Diseases and Multiple Sclerosis Based on Protein Markers

Ashmita Dey, Dwipanjan Sanyal, Krishnananda Chattopadhyay iD, Ujjwal Maulik, Vladimir N Uversky iD, Sagnik Sen

International Journal of Molecular Sciences · 22.06.2026 · 27 (12) · 5627

DOI: 10.3390/ijms27125627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.06.2026. Verfasst von Ashmita Dey und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Scinece and Engineering, SRM University-AP, Amaravati 522 240, India. Hauptthemen laut MEDLINE: Multiple Sclerosis, Biomarkers, Neurodegenerative Diseases. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSIR-IICB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroinflammation is a key hallmark of both neurodegenerative and neurospecific autoimmune diseases, including multiple sclerosis (MS), where immune dysregulation contributes to cellular stress, autophagy, and disease progression in Alzheimer’s disease (AD), Parkinson’s disease (PD), and MS. Emerging evidence suggests a shared mechanism behind MS, AD, and PD, driven by chronic interaction between the peripheral immune system and the central nervous system (CNS). While MS was traditionally viewed as a primary autoimmune condition, recent research indicated that all three disorders involve a breakdown of the blood–brain barrier (BBB). This structural failure enables peripheral immune cells and cytokines to enter the brain, causing sustained neuroinflammation and accelerating disease progression. Here, we propose an end-to-end framework for identification of the diagnostic and therapeutic cell-specific protein markers commonly regulated in mild–moderate AD (MMAD), early-stage PD (ESPD), and MS within peripheral blood mononuclear cells (PBMCs). PBMC markers were first identified based on shared differential protein expression, followed by filtering for BBB permeability. Subsequently, sorted cell markers were mapped to disease-specific neural cell types. Our analysis suggests that PBMC-derived cells, including astrocyte- and monocyte-like populations, share overlapping transcriptional signatures and functional similarity with macrophages and neuroglial cells, indicating potential transcriptional similarity or functional convergence. Furthermore, intra- and inter-cellular pathway analysis suggested both shared and disease-specific signaling mechanisms, with kinase–integrin interactions emerging as key regulatory factors. Selected potential seed markers, primarily kinases and immunoglobulins, were further analyzed through evolutionary sequence–structure space to identify druggable structural features. Next, protein moonlighting possibilities were tested to enhance the temporal functional trajectory of the markers for precise therapeutic impact. Hence, the framework provides a robust strategy to identify immune-based disease-specificcandidate diagnostic andpotential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisBiomarkersNeurodegenerative DiseasesHumansBlood-Brain BarrierLeukocytes, MononuclearAlzheimer Disease

Stichwörter der Autor:innen

blood–brain barrier dysfunctioncell-specific protein markersdruggable targetsimmune–CNS crosstalkneuroinflammationtranscriptomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Computer Scinece and Engineering, SRM University-AP, Amaravati 522 240, India.
  • Structural Biology and Bioinformatics, CSIR-Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road, Kolkata 700 032, India.
  • Department of Computer Science and Engineering, Jadavpur University, Kolkata 700 032, India.
  • Department of Molecular Medicine and USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
  • Molecular Genetics and Genomics Division, New England Biolabs, Ipswich, MA 01938, USA.

ORCID-Profile: Krishnananda Chattopadhyay, Vladimir N Uversky

Förderung

  • CSIR-IICB

Zitieren

APA

Dey, A., Sanyal, D., Chattopadhyay, K., Maulik, U., Uversky, V. N., & Sen, S. (2026). IMMUND: A Diagnostic and Therapeutic Pipeline to Uncover the Convergence in Functional Perturbation at Early Stages of Neurodegenerative Diseases and Multiple Sclerosis Based on Protein Markers. International Journal of Molecular Sciences, 27(12), 5627. https://doi.org/10.3390/ijms27125627

Vancouver

Dey A, Sanyal D, Chattopadhyay K, Maulik U, Uversky VN, Sen S. IMMUND: A Diagnostic and Therapeutic Pipeline to Uncover the Convergence in Functional Perturbation at Early Stages of Neurodegenerative Diseases and Multiple Sclerosis Based on Protein Markers. International Journal of Molecular Sciences. 2026;27(12):5627. doi:10.3390/ijms27125627

BibTeX
@article{Dey2026,
  author = {Dey, Ashmita and Sanyal, Dwipanjan and Chattopadhyay, Krishnananda and Maulik, Ujjwal and Uversky, Vladimir N and Sen, Sagnik},
  title = {IMMUND: A Diagnostic and Therapeutic Pipeline to Uncover the Convergence in Functional Perturbation at Early Stages of Neurodegenerative Diseases and Multiple Sclerosis Based on Protein Markers},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5627},
  doi = {10.3390/ijms27125627}
}
Kostenlos starten →